The term neurodegenerative as applied to diseases of has allowed us to reach down to the nuclear participants of the glutamate-evoked cell death program the nervous system is used to designate a group of disorders in which there is gradual, generally including transcription factors and their targeted genes. 3 Among the transcription factors that are actisymmetric, relentlessly progressive wasting away of neurons for reasons still unknown. A striking feature vated by glutamate in neuronal cells, there are proteins belonging to the NF-B/Rel family. 4 Recent work sugof a number of disorders of this class is the almost selective involvement of anatomically and physiologigests a pivotal role of these regulatory proteins along the glutamate-evoked cascade of events leading to cell cally related subgroups of neurons. The abnormal loss of neurons that may occur during development or as a death since blockade of their activation can result in effective neuroprotection. 5 result of an injury represents the functional substrate of many symptoms easily detectable in a number of Until recently, the properties of NF-B/Rel proteins have been most extensively exploited in cells of the neurological and psychiatric disorders. The understanding of the mechanisms that account for specific immune system or, more in general, in periphery, where these regulators are implicated in the transcripneuronal dysfunction and death in these diseases represents a major challenge for both clinical and basic tional control of genes involved in inflammatory, immune, and acute phase responses. 4 Some recent neuroscientists.
In the last years dysfunction of the ionotropic glutareports have suggested that NF-B/Rel proteins are likely to participate in normal and pathological brain mate-activated neurotransmitter receptors, which are the principal providers of fast neurotransmission in function. [6] [7] [8] Despite these important contributions, very little is known on the CNS genes whose mammalian brain, has been extensively implicated since excessive or persistent activation of these recepexpression is under NF-B control. We recently found that two major pathogenic pathways which are likely tors results in neuronal death by excitotoxicity.
1 Brain damage through excitotoxicity has been closely assoto contribute to the neuropathology associated with Alzheimer's disease, namely the inflammatory cytociated with acute conditions like stroke, trauma, ischaemia, hypoglycemia, but also with epilepsy and kine IL-1␤ and glutamate, can contribute to NF-B induction.
9-10 We also tested whether anti-inflamma-ALS. A contribution of excitotoxicity to chronic and progressive neuropathologies like Alzheimer's and Partory drugs, and aspirin in particular, may prevent glutamate-induced NF-B activation in neuronal cells. kinson's diseases has also been suggested.
2
Interference with glutamate receptor function has Why aspirin? There are several reasons that made these drugs extremely interesting from our point of view. been extensively explored as a means to develop compounds able to attenuate or prevent excitotoxicity.
First, clinical and experimental evidence has suggested that inflammation may be a common component of More recently, the search for novel targets for pharmacological manipulation of excitotoxicity has been several neurodegenerative conditions, anti-inflammatory therapy for treatment of rheumatoid erative disorders has still to be evaluated but it could be of great relevance. These molecules would appear arthritis.
11 In a small clinical trial, indomethacin has demonstrated some efficacy in slowing down proto possess a wider pharmacological spectrum compared to other NSAID. In view of their dual and disgression in people affected by AD.
12 Finally, Kopp and Gosh 13 showed that salicylates are endowed with the tinct ability of acting not merely as anti-inflammatory compounds but also directly as antidegenerative molability to block NF-B activation. This mechanism has been purported to be highly contributory to the ecules, we would predict a potential great benefit from the employment of aspirin-derived drugs in neurodegpharmacological properties of these drugs since the key role of NF-B proteins is controlling immune and enerative processes. Furthermore these results may open up interesting perspectives in the development of inflammatory function.
Under these exciting premises, we tested whether, at novel strategies for therapeutic intervention in neurodegenerative states, namely a transcriptional pharmaconcentrations compatible with plasma levels reached during treatment of chronic inflammatory states, cological approach. aspirin and sodium salicylate may interfere with glutamate-induced activation of NF-B and cell death. Both M Grilli and M Memo Section of Pharmacology drugs turned out to be effectively neuroprotective. Surprisingly, the neuroprotective effect did not appear to Dept Biomedical Sciences and Biotechnologies University of Brescia, Medical School correlate with the anti-inflammatory properties of this compound since: (i) indomethacin was inactive; (ii) in Via Valsabbina 19, 25123 Brescia, Italy our experimental settings, aspirin was equi-or more potent than its metabolite salicylic acid. The molecular target for aspirin and sodium salicylate to exert neuroprotection appeared to be localized downstream of the
